— Know what they know.
Not Investment Advice

SNOA NASDAQ

Sonoma Pharmaceuticals, Inc.
1W: -2.4% 1M: -3.9% 3M: -0.8% YTD: -65.9% 1Y: -67.9% 3Y: -92.2% 5Y: -98.8%
$1.24
-0.01 (-0.80%)
 
Weekly Expected Move ±4.7%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $5.9M mcap · 5M float · 2.71% daily turnover · Short 19% of daily vol

Balance Sheet Trends

Total Assets
$14M +1.9% ▲
5Y CAGR: -1.4%
Total Liabilities
$11M +17.1% ▲
5Y CAGR: +2.5%
Shareholders Equity
$3M -29.8% ▼
5Y CAGR: -10.4%
Cash & Investments
$2M -55.4% ▼
5Y CAGR: -10.7%
Total Debt
$842K +176.1% ▲
5Y CAGR: -20.6%
Net Debt
-$2M +69.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$7M$4M$3M$5M$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$7M$4M$3M$5M$2M
Net Receivables$2M$3M$6M$4M$5M
Inventory$3M$3M$3M$3M$4M
Other Current Assets$218K$240K$367K$360K$383K
Total Current Assets$16M$14M$13M$13M$12M
Property, Plant & Equip.$879K$906K$651K$309K$912K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$707K$578K$396K$147K$64K
Total Non-Current Assets$2M$2M$2M$1M$2M
Total Assets$19M$16M$15M$14M$14M
— Liabilities —
Accounts Payable$2M$841K$607K$953K$2M
Short-Term Debt$808K$431K$323K$220K$222K
Deferred Revenue$1M$160K$478K$641K$284K
Other Current Liabilities$784K$566K$694K$487K$533K
Total Current Liabilities$6M$4M$4M$4M$5M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$4M$4M$5M$5M$6M
Total Non-Current Liabilities$4M$5M$5M$5M$6M
Total Liabilities$10M$8M$9M$9M$11M
— Equity —
Common Stock$2K$5K$2K$0$0
Retained Earnings-$184M-$190M-$194M-$198M-$201M
Accumulated OCI-$4M-$3M-$3M-$4M-$3M
Total Stockholders Equity$9M$8M$6M$4M$3M
Total Liabilities & Equity$19M$16M$15M$14M$14M
— Key Metrics —
Total Debt$1M$849K$608K$305K$842K
Net Debt-$6M-$3M-$3M-$5M-$2M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms